Showing results (1161-1170 of 1,278) with videos related to
Sort By:
Pageof 128
Psychopharmacology Bulletin|January 1, 1991
Plasma fluphenazine levels and clinical response in newly admitted schizophrenic patientsT Van Putten, M Aravagiri, S R Marder, et al.Psychopharmacology Bulletin|May 8, 2004
Bupropion sustained release for panic disorderNaomi M Simon, Naresh Emmanuel, James Ballenger, et al.Psychopharmacology Bulletin|May 8, 2004
Evidence-based practice: how to evaluate what you readK Ranga Rama KrishnanPsychopharmacology Bulletin|May 8, 2004
Risperidone in the management of psychiatric and neurodegenerative disease in the elderly: an updateC Lindsay DeVane, Jacob MintzerPsychopharmacology Bulletin|May 8, 2004
The role of GABA in the pathophysiology and treatment of anxiety disordersCharles B NemeroffPsychopharmacology Bulletin|July 28, 2004
Drug development for anxiety disorders: new roles for atypical antipsychoticsWilliam H Carson, Hisashi KitagawaPsychopharmacology Bulletin|November 17, 2007
Defining the clinical course of bipolar disorder: response, remission, relapse, recurrence, and rougheningRobert Ma Hirschfeld, Joseph R Calabrese, Mark A Frye, et al.Psychopharmacology Bulletin|February 8, 2007
Leptin and leptin receptor gene polymorphisms and increases in body mass index (BMI) from olanzapine treatment in persons with schizophreniaVicki L Ellingrod, Jeffrey R Bishop, Jessica Moline, et al.Psychopharmacology Bulletin|February 8, 2007
Pulmonary hypertension during lithium therapy: clinical case studyM E Ceylan, M H AlpsanPageof 128